It is pertinent to mention here that the Drug Regulatory Authority of Pakistan (DRAP) had allowed clinical trials of blood plasma therapy to treat coronavirus patients in the country.
Plasma, the fluid in blood teeming with antibodies post-illness, has already proven effective in small studies to treat infectious diseases including Ebola and SARS.